Abiomed Inc (NQ: ABMD )

328.52 USD +4.98 (+1.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2021 Add to My Watchlist

Price and Volume

Volume	148,018
Open	327.44
Bid (Size)	328.07 (1)
Ask (Size)	328.53 (9)
Prev. Close	323.54
Today's Range	323.84 - 328.84
52wk Range	242.73 - 387.40
Shares Outstanding	45,295,979
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification

July 15, 2021

Abiomed to release financial results for the first quarter of the fiscal year 2022 on Thursday, August 5, 2021.

FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure

June 29, 2021

Abiomed’s (NASDAQ: ABMD) newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) as safe and effective to treat acute...

Performance

YTD	+3.72%	+3.72%
1 Month	+2.12%	+2.12%
3 Month	-6.41%	-6.41%
6 Month	-5.57%	-5.57%
1 Year	+11.53%	+11.53%

More News

Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

June 01, 2021

Analysts See 11% Upside For The Holdings of RSP

July 20, 2021

Abiomed to Present at Upcoming Investor Conferences

May 25, 2021

Noteworthy Monday Option Activity: COF, ABMD, HYFM

July 12, 2021

GoDaddy Larger Than S&P 500 Component ABIOMED

July 06, 2021

Noteworthy ETF Outflows: RSP, GNRC, RMD, ABMD

June 30, 2021

Noteworthy Friday Option Activity: ABMD, UNP, CCL

June 18, 2021

Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin

April 29, 2021

Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella

April 28, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.